Sartorius Stedim Biotech Reports H1 2024 Results
Company Announcements

Sartorius Stedim Biotech Reports H1 2024 Results

Sartorius Stedim Biotech (FR:DIM) has released an update.

Sartorius Stedim Biotech has released its first-half 2024 financial results and provides forecasts for the rest of the year. The internationally active biopharmaceutical partner reported a turnover of approximately 2.8 billion euros in 2023 and employs around 10,600 people globally. The full investor news is available on the company’s website.

For further insights into FR:DIM stock, check out TipRanks’ Stock Analysis page.

Related Articles
Howard Kim0RG8 Upcoming Earnings Report: What to Expect?
TipRanks European Auto-Generated NewsdeskSartorius Stedim Biotech Adjusts 2024 Outlook
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App